Company intelligence
B-Secur
Committed to reducing CVD-related preventable deaths through advanced biosensing technology.
About B-Secur
B-Secur is committed to reducing preventable deaths from cardiovascular disease (CVD) through advanced, clinically validated biosensing algorithms that enable early diagnosis and proactive health management. With decades of academic R&D in ECG analysis and front-end design and origins in biometric security, our expertise in noise artifact detection and reduction delivers FDA-cleared clinical-grade ECG solutions for next-generation wearable health devices and platforms. HeartKey® is a suite of powerful ECG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights: *Cloud- and chip-based solutions *Clinically validated ECG algorithms and analytics *Platform agnostic solutions *High accuracy on dry electrodes in real time *Proprietary AI machine-learning and filter techniques We partner with world-leading technology companies to enable innovation, speed to market and operational efficiencies for next-generation medical and consumer devices and platforms.
Verified activity
Signals from B-Secur
2 published signals
Presence & Recognition
B-Secur announced that Blythe Karow is bringing together experts to discuss the ECG testing gap and device credibility.
Reported by B-Secur
Presence & Recognition
B-Secur hosted Marv van Niekerk and Gillian Pritchard at the Digital Lean Tour for the company.
Reported by Brajith Srigengan